Search
JOIN US
Contact
Ouvrir le menu
Menu
Home
Getting to know us
Alain Gorny
Nicolas Sauvage
Stéfanie Oudard
Donatienne Blin
Diane Bandon-Tourret
Mélanie Race-Chapelle
Ariane Bretz
Esther Vogel
Joyce Valencia
Clémence Crepy
Make Sea your choice
You are ...
We are ...
We offer ...
Our recognized expertise...
Our expertise
Healthcare law
Medical ethics & transparency legislation / compliance
Advertising, promotion and medical information
Litigation, product and image defense
Healthcare class actions
Mediation
Business regulation
Placing on the french market
Safety & supply agreements
Distribution, partnership and promotion agreements
Price and reimbursement, market access, pricing, evaluation and re-evaluation
Borderline products
Medical research agreements
Hospital public procurement
New medical devices regulation
E-health
Digital law
Drafting and negotiating IT contracts
IT pre-litigation management
GDPR and [DP] audit ensuring compliance and awareness
Protecting personal data and Big Data
Intellectual property of intangible assets
Websites and mobile apps
Blockchain
Artificial intelligence
IT public procurement
Digital & labor law
Mediation, litigation and IT expertise
Personal health data
E-health
Labor law
Employment contract
Remuneration
Working hours
Discrimination and harassment
Ethics and compliance
Collective negotiations
Reorganization / restructuring
Termination of employment contract
Social protection
Medicine and work
Commercial law
Termination of established commercial relations
Unfair competition
Commercial agreements
Life Sciences
FAQ
Emergence of alternative pricing models
Entering the french market
Disruptive players in the pharma/MD sector
Pressure by the health insurance bodies on costs strains market access
Ever increasing regulation leads to consolidations
New care delivery models
AI and Big Data prefigure the new healthcare context
Advisory & Digital
FAQ
Recruiting and retaining increasingly transitory human resources
Ensuring that algorithms and Big Data are ethical
The increasing complexity of the business environment
Open innovation approaches
Being flexible!
Being compliant!
International contacts and networks
News
Contact
Join us
You are here :
Life Sciences
FAQ
FAQ
Life sciences
Am I required to
declare
an agreement concluded between my pharmaceutical firm and an
association
of healthcare professionals?
I suspect one of my competitors is using
information confidential
to my company
My employees’ remuneration is
variable.
May I
oblige
them to accept a
change
?
How can I
train
my teams to comply with
anti-bribery law
and the directives of my parent company?
May I challenge a
negative opinion
handed down by the professional Council?
Consolidated, my
(foreign) group
is profitable worldwide, but the French subsidiary makes heavy losses; may I make
redundancies
?
My competitor has just put a
misleading comparative advertisement
online.
On the basis of
religious belief
one of my
research pharmacists refuses to obey their hierarchical superior
, demanding she is replaced by a man.
How can I make my
advertising campaign
successful whilst complying with the applicable regulations?
I am setting up a
Cloud
solution, an
app
, a new
ERP
system. Do I need to raise this with the
CSE
?
I have been served
summons
challenging one of my products.
I am threatened with a
class action
relating to one of my healthcare products.
I am involved in
legal action
with one of my commercial partners but wish to
preserve our relationship.
A physician is
improperly granting renewed sick leave notices
for one of my employees.
The mechanism of
collective termination agreements
seems appropriate to my company’s situation. What is your opinion?
What if I launched an
e-health
project?
I wish to launch a new
healthcare
project, but am not sure if the French and European
regulations
allow it.
An employee
committed suicide
at home, leaving behind an ambiguous letter regarding the
role of the firm
in their decision.
An employee
committed suicide
at home, leaving behind an ambiguous letter regarding the
role of the firm
in their decision.
I am outsourcing
one of my company’s crucial activities to a
CSP
.
My MA has been
suspended
by ANSM...
I am being
inspected by ANSM
, what should I do to ensure my PV contracts comply?
I wish to
distribute
my healthcare products on the
French market,
what is the best way to achieve this?
An employee has presented a notice of sick leave on the grounds of “work-related
anxio-depressive syndrome
”.
I wish to set up a
distribution network abroad
My product has been removed from the
list of drugs billable over and above inpatient services...
How is it possible to
increase
the share of
healthcare and provident
contributions
paid by my employees?
Our turnover is dwindling without us noting any loss. Is it possible to make
redundancies
?
I want to obtain approval for
reimbursement
for an
innovative
healthcare solution.
My product does not have the same
status
throughout Europe...
May I
refuse to pay
the
fees
of an expert consultant appointed by the
staff representative bodies
?
The professional council has issued a negative opinion concerning my company’s tripartite
biomedical research
agreement
What services may I offer in my bid in response to a
call for tender
to make my offer stand out from my competitors?
The new
European Regulation
on medical devices is coming into force, what changes will this involve?
As part of my clinical trial, I process
health data.
My employees on a
‘days worked’
package refuse to
badge in...
May I
challenge
a notice of
occupational injury
or of
work-related illness
by an
employee
who claims they are subject to
harassment
?
How can an
amicable termination
be initiated with an employee?
Am I
obliged
to put a
redundancy plan
into place in order to
reduce the number of employees
?